| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |